Role of Minor Groove Width and Hydration Pattern on Amsacrine Interaction with DNA.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069933
- By:
- Publication type:
- Article
Works matching DE "AMSACRINE (Drug)"
Results: 10
1
2
Molecular cytogenetic evaluation of the mechanism of genotoxic potential of amsacrine and nocodazole in mouse bone marrow cells.
- Published in:
- Journal of Applied Toxicology, 2013, v. 33, n. 6, p. 426, doi. 10.1002/jat.1753
- By:
- Publication type:
- Article
3
Chemical Degradation of Wastes of Antineoplastic Agents Amsacrine, Azathioprine, Asparaginase and Thiotepa.
- Published in:
- Annals of Occupational Hygiene, 1998, v. 42, n. 4, p. 259, doi. 10.1016/S0003-4878(98)00023-4
- By:
- Publication type:
- Article
4
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML.
- Published in:
- Annals of Hematology, 2017, v. 96, n. 3, p. 479, doi. 10.1007/s00277-016-2887-4
- By:
- Publication type:
- Article
5
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1397, doi. 10.1007/s00277-013-1790-5
- By:
- Publication type:
- Article
6
CK0403, a 9-aminoacridine, is a potent anti-cancer agent in human breast cancer cells.
- Published in:
- Molecular Medicine Reports, 2016, v. 13, n. 1, p. 933, doi. 10.3892/mmr.2015.4604
- By:
- Publication type:
- Article
7
Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair <italic>M. smegmatis</italic> Growth and Disturb Chromosome Replication.
- Published in:
- Frontiers in Microbiology, 2018, p. N.PAG, doi. 10.3389/fmicb.2018.01592
- By:
- Publication type:
- Article
8
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 5, p. 475, doi. 10.1111/ejh.12615
- By:
- Publication type:
- Article
9
The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55365-7
- By:
- Publication type:
- Article
10
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
- Published in:
- Leukemia & Lymphoma, 2013, v. 54, n. 2, p. 336, doi. 10.3109/10428194.2012.713479
- By:
- Publication type:
- Article